These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Hazenberg BP; Van Leeuwen MA; Van Rijswijk MH; Stern AC; Vellenga E Blood; 1989 Dec; 74(8):2769-70. PubMed ID: 2510837 [No Abstract] [Full Text] [Related]
27. Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man. Appelbaum FR; Nemunaitis J; Singer JW; Buckner CD; Storb R; Thomas ED Haematol Blood Transfus; 1990; 33():736-40. PubMed ID: 2182464 [No Abstract] [Full Text] [Related]
28. Gas gangrene and congenital agranulocytosis. Seidel M; Weiss M; Nicolai T; Roos R; Grantzow R; Belohradsky BH Pediatr Infect Dis J; 1990 Jun; 9(6):437-40. PubMed ID: 2195460 [No Abstract] [Full Text] [Related]
29. Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity. Oh EJ; Chae HJ; Park YJ; Park JW; Han K Am J Hematol; 2007 Jun; 82(6):500. PubMed ID: 17266051 [No Abstract] [Full Text] [Related]
30. Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor. Somogyi A; Rosta A; Lang I; Werling K Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):119-24. PubMed ID: 8836317 [TBL] [Abstract][Full Text] [Related]